April 19, 2017—(BRONX, NY)—On Monday, April 24, the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research at Albert Einstein College of Medicine will host its third Stem Cell Symposium, focusing on the importance of cell metabolism and epigenetics. Leading scientists from the U.S., Japan and Germany will present their latest research and describe the hurdles to translating new findings into therapeutics.
Paul S. Frenette, M.D.“The newest developments in stem cell biology – particularly in epigenetics – may prove transformative in the field, leading to treatments for cancer and in regenerative medicine,” says Paul Frenette, M.D., chair and director of Einstein’s Gottesman Institute for Stem Cell and Regenerative Medicine Research, and professor of medicine and of cell biology. “In addition to educating attendees, we hope the event will spark new research collaborations among Einstein faculty members and with scientists at other institutions.”
The symposium will be held from 1:00 to 5:30 p.m. at LeFrak Auditorium in the Michael F. Price Center for Genetic and Translational Medicine/Harold and Muriel Block Research Pavilion on Einstein ‘s Jack and Pearl Resnick Campus. The scheduled lectures are:
9/11 World Trade Center Exposure Linked to Heart Disease Among NYC Firefighters
On Becoming a Physician: New Einstein Students Receive White Coats and Stethoscopes
Novel Therapy for Acute Migraine Shows Promise in Phase 3 Clinical Trial
First Complete Wiring Diagram of an Animal's Nervous System
Multimillion Dollar NIH Grant to Help Reduce Opioid Use & Get Care to People Who Need It
NIH Grant Funds $23 Million Study of Diseases Affecting People Living with HIV
New TAILORx Data Guides Adjuvant Therapy in Younger Breast Cancer Patients
Einstein Celebrates Its 61st Commencement
Bolstering Biopsies: Testing Patients' Individual Cells to Guide Treatment
Tablet Blog